Home LiteratureArticle Details
PMID: 9651658 Published · ppublish English Journal Article

Prognostic relevance of immunohistology, tumor size and vascular space involvement in axillary node negative breast cancer.

Archives of gynecology and obstetrics ·Vol. 261 ·No. 3 ·1998-00-00 ·Pages 139-46

Lampe B, Hantschmann P, Dimpfl T

Abstract

Adjuvant treatment for patients with axillary node negative (ANN) breast cancer is controversial because operation alone gives a 70% cure rate. Features which predict recurrence are needed and we therefore evaluated the predictive value of tumor diameter and vascular involvement as well as of estrogen receptors (ER), progesterone receptors (PR), p53, MIB-1, c-erb and PCNA demonstrated by immunohistological staining in 178 patients with ANN breast cancer. Although ER status, tumor diameter and vascular space involvement were significantly correlated to the development of recurrence, their sensitivity, specificity and predictive value were too low to give them clinical value.

MeSH Terms
Axilla Biomarkers, Tumor/analysis Breast/pathology Breast Neoplasms/blood supply,mortality,pathology Female Humans Immunoenzyme Techniques Lymph Nodes/pathology Mastectomy, Modified Radical Mastectomy, Segmental Neovascularization, Pathologic/pathology Prognosis Survival Rate
Chemicals
Biomarkers, Tumor
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Lampe B
I. Frauenklinik, Klinikum Innenstadt, Ludwigs-Maximilians-Universität, München, Germany.
Hantschmann P
Dimpfl T
Article Info
Journal
Archives of gynecology and obstetrics
Abbr.
Arch Gynecol Obstet
ISSN
0932-0067
Published
1998-00-00
Pages
139-46
Language
English
Region
Germany
NLM ID
8710213
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com